Oximeter for COVID-19: Sellers using loopholes in India s MRP regime to overcharge downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Probe ordered in mega-corruption in Remdesivir supplies: CVC
By
Quaid Najmi ( IANS) |
Published on
Wed, May 12 2021 18:42 IST |
10 Views
remdesivir injection. Image Source: IANS News
Mumbai, May 12 : Nearly a month after a Maharashtra activist alleged a massive scam in the supplies and availability of key anti-viral drug Remdesivir injections, the Chief Vigilance Commissioner has finally ordered a probe.
Taking cognizance of a petition by Barrister Vinod Tiwari, the CVC has ordered the Chief Vigilance Officer (CVO) of Ministry of Chemicals & Fertilisers to investigate the issue in detail.
In a communication to Tiwari dated May 11, the CVC has said that the complaint has been duly examined by the Commission and having regards to the nature of the issues raised therein , it has been sent to the CVO of the ministry for a probe.
Nearly a month after a Maharashtra activist alleged a massive scam in the supplies and availability of key anti-viral drug Remdesivir injections, the Chief Vigilance Commissioner has finally ordered a probe.
Taking cognizance of a petition by Barrister Vinod Tiwari, the CVC has ordered the Chief Vigilance Officer (CVO) of Ministry of Chemicals & Fertilisers to investigate the issue in detail.
In a communication to Tiwari dated May 11, the CVC has said that the complaint has been duly examined by the Commission and having regards to the nature of the issues raised therein , it has been sent to the CVO of the ministry for a probe.
COVID-19: SC asks Centre to consider fixing ceiling price for drugs
The court said it has been informed by the Centre that NPPA has revised the maximum retail price of Remdesivir to Rs 3,500.
BusinessToday.In | May 3, 2021 | Updated 01:22 IST
The court said the Centre can consider invoking its statutory powers under the Drugs Price Control Order.
The Supreme Court on Sunday asked the Centre to consider fixing ceiling price for drugs like Favipiravir, Tociluzumab, among others, used for treatment of COVID-19 patients as they are being sold at exorbiant rates.
The court said it has been informed by the Centre that the National Pharmaceutical Pricing Authority (NPPA) has revised the maximum retail price of Remdesivir, an anti-viral drug used in COVID-19 treatment, to Rs 3,500. However, it has come to our notice that several other drugs which are being prescribed by doctors for treating COVID-19 patients like Favipiravir, Tociluzumab, Enoxaparin, Ivermectin, Methylprednisolone, P
COVID-19: SC asks Centre to consider fixing ceiling price for drugs
The court said it has been informed by the Centre that NPPA has revised the maximum retail price of Remdesivir to Rs 3,500.
BusinessToday.In | May 3, 2021 | Updated 01:22 IST
The court said the Centre can consider invoking its statutory powers under the Drugs Price Control Order.
The Supreme Court on Sunday asked the Centre to consider fixing ceiling price for drugs like Favipiravir, Tociluzumab, among others, used for treatment of COVID-19 patients as they are being sold at exorbiant rates.
The court said it has been informed by the Centre that the National Pharmaceutical Pricing Authority (NPPA) has revised the maximum retail price of Remdesivir, an anti-viral drug used in COVID-19 treatment, to Rs 3,500. However, it has come to our notice that several other drugs which are being prescribed by doctors for treating COVID-19 patients like Favipiravir, Tociluzumab, Enoxaparin, Ivermectin, Methylprednisolone, P